Flexible Liquid Crystal Optrode for Label-Free Electro-Optical Electrophysiological Recording

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Npj Flexible Electronics. https://doi.org/10.1038/s41528-026-00625-6  
Dr. Reem M. Almasri  et al.

Points

University of New South Wales researchers developed a flexible polymer-based optrode that passively converts physiological electrical signals directly into quantifiable light outputs.
The soft sensor utilizes high-performance polymers that maintain full functional conductivity even after undergoing 10,000 mechanical bending cycles in testing.
Embedded liquid crystals detect submillivolt electrical amplitudes by realigning their angular orientation in response to endogenous heart and brain signals.
Miniaturization down to tens of microns maintains high signal clarity without requiring bulky local amplifiers or generating thermal damage in surrounding tissue.
In vitro biocompatibility testing demonstrated a 98.4% cell viability rate, confirming that the soft device supports normal cell growth without causing cytotoxicity.

Summary

This study evaluated the feasibility of a flexible, polymer-based optical-electrode (“optrode”) employing a passive transduction mechanism to convert endogenous biopotentials directly into quantifiable optical signals. Conventional bioelectronic implants rely on rigid silicon and metal components that create mechanical mismatches with moving tissues, causing scarring or rejection. Led by Reem Almasri, Nigel Lovell, and Francois Ladouceur at the University of New South Wales, the team sought to engineer a soft, label-free electro-optical recording device capable of high-resolution electrophysiological monitoring without local amplifiers or electrical interference.

The optrode architecture replaces brittle conductive wires with a specialized polymer that maintains mechanical integrity after 10,000 bending cycles. Sandwiched within the flexible matrix is a layer of highly sensitive liquid crystals that realign their angular orientation relative to applied submillivolt biopotentials. This passive mechanism detects submillivolt signal amplitudes typical of cardiac and neuronal activity, converting voltage fluctuations into optical percentage changes. Because the passive transduction mechanism eliminates bulky local amplifiers, the sensor footprint can be miniaturized to tens of microns—roughly half the diameter of a human hair—without introducing environmental electrical noise.

In vitro cell culture evaluations demonstrated biocompatibility, recording a 98.4% cell viability rate with normal growth patterns comparable to standard silicon controls. Preclinical animal testing validated label-free electro-optical transduction in vivo, demonstrating immune-to-interference signal transmission suitable for high-density neural and cardiac recording. The authors conclude that flexible liquid crystal optrodes represent a viable, non-toxic platform for long-term physiological monitoring, with ongoing development focused on expanding recording bandwidth beyond 10 kHz to capture single-neuron firing dynamics.

Link to the article: https://www.nature.com/articles/s41528-026-00625-6

References

Almasri, R. M., Chen, Y., Ladouceur, F., Aregueta Robles, U. A., Feng, Z., Poole-Warren, L. A., Lovell, N. H., & Al Abed, A. (2026). Flexible polymer-based liquid crystal sensor for label-free electro-optical recording of electrophysiological activity. Npj Flexible Electronics. https://doi.org/10.1038/s41528-026-00625-6